BioCrossroads announces DataX BioInnovation Challenge

Competition Was Developed to Encourage Intersection of It with Life Sciences Research on Two Hoosier Health Issues Diabetes and Opioid Addiction

 As a way to foster artificial intelligence and machine learning as key tools to realizing new discoveries in the life sciences, BioCrossroads announced a new competition where innovators can use data sets to identify and investigate a hypothesis aimed at improving two Indiana health issues – diabetes and opioid abuse. The BioCrossroads DataX BioInnovation Challenge was created to intersect life sciences and data research and encourage new ways of investigating traditional disease biology and public health outcomes’ questions. Founded on the premise that asking critical questions can leverage and bridge publicly available data sets, the Challenge seeks to foster new solutions and innovation.

How it Works:

The BioCrossroads DataX BioInnovation Challenge seeks creative U.S. based individuals, labs, and start-ups to identify and explore critical issues in diabetes health and opioid addiction that can be addressed by using public data as a springboard. Proposals will include:

• A focus on diabetes care or opioid addiction- both health issues impacting Hoosiers.
• A hypothesis using insights from data sets relating to how the health issue could be improved.
• Description of an experiment that would test the hypothesis using data sets and/or biological samples.
• Hypotheses and proposed solutions must be data driven.
• Hypotheses and proposed solutions should focus on improvements that impact disease identification, management, diagnosis, and/or treatment.
• Impact can be at the patient, provider, and/or health care systems network level.

Read More: What the FCA’s 18th Month Delay with SCA Could Mean for Online Payments

Teams may be within a corporate group, academic institution, independent or any combination thereof.  Teams do not have to be based in Indiana; however, the winning team is expected to engage the local ecosystem and will be required to share results of the experiment at the BioCrossroads’ Indiana Life Sciences Summit in 2020. Up to $50,000 in cash will be awarded to the winning team(s).

Read More: Jeffrey Catanzaro Joins Integreon as SVP of Contracts, Compliance and Commercial Services

“The collision of life sciences’ traditional biology and pharmacology with technology and big data has enormous potential for bettering health outcomes. Innovation and growth requires interdisciplinary collaboration to evolve and create capabilities,” said Patricia Martin, president and CEO of BioCrossroads.  “In Indiana, an opportunity exists to foster cross-fertilization amongst the life sciences, technology, and engineering sectors. Simply put, there are discoveries hidden in data that can change the world. We are excited to see what ideas surface from this challenge.”

Read More: How to Use PXM to Survive the Fourth Industrial Revolution